J
Julien Taieb
Researcher at University of Paris
Publications - 482
Citations - 11958
Julien Taieb is an academic researcher from University of Paris. The author has contributed to research in topics: Colorectal cancer & Medicine. The author has an hindex of 50, co-authored 409 publications receiving 8679 citations. Previous affiliations of Julien Taieb include Paris Descartes University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valérie Vilgrain,Valérie Vilgrain,Helena Pereira,Eric Assenat,Boris Guiu,Alina Diana Ilonca,Georges-Philippe Pageaux,Annie Sibert,Mohamed Bouattour,Rachida Lebtahi,Wassim Allaham,Hélène Barraud,Valérie Laurent,Elodie Mathias,Jean-Pierre Bronowicki,Jean-Pierre Tasu,Rémy Perdrisot,Christine Silvain,René Gerolami,Olivier Mundler,Jean-François Seitz,Vincent Vidal,Christophe Aubé,Frédéric Oberti,Olivier Couturier,Isabelle Brenot-Rossi,Jean-Luc Raoul,Anthony Sarran,Charlotte Costentin,Emmanuel Itti,Alain Luciani,Alain Luciani,René Adam,Maïté Lewin,Didier Samuel,Maxime Ronot,Maxime Ronot,Aurelia Dinut,Laurent Castera,Laurent Castera,Gilles Chatellier,Gilles Chatellier,Elisabeth Delhom Christol,Alina D. Ilonca,Julie Lonjon,Mohamed Abdel-Rehim,Arnaud Dieudonné,Christophe Bazin,Carine Chagneau-Derrode,Patrick Borentain,Antoine Bouvier,Laurent Vervueren,Julia Chalaye,Hicham Kobeiter,Julien Edeline,Etienne Garin,Yan Rolland,Isabelle Archambeaud,T. Eugène,Eric Frampas,Christophe Cassinotto,Martine Guyot,Jean-Baptiste Hiriart,Bruno Lapuyade,Julien Vergniol,Philippe Bachellier,Julien Detour,Bernard Duclos,Michel Greget,Francois Habersetzer,Alessio Imperiale,Philippe Merle,Agnès Rode,Julie Morvan,Eric Nguyen-Khac,Thierry Yzet,G. Baudin,Patrick Chevallier,Abakar Mahamat,Thierry Piche,Micheline Razzouk,Patrick Hillon,Romaric Loffroy,Michel Toubeau,Julie Vincent,Gabriele Barabino,Nadia Bouarioua,Muriel Cuilleron,Marie Ecochard,Nathalie Prevot-Bitot,Vincent Leroy,J. Roux,Christian Sengel,Valérie Bourcier,Nathalie Ganne-Carrié,Olivier Seror,Sylvie Costo,Thong Dao,Jean-Pierre Pelage,Jérôme Dumortier,Francesco Giammarile,Pierre-Jean Valette,Nadia Ghazzar,Olivier Pellerin,Julien Taieb,Pierre Weinmann,Alexandra Heurgue-Berlot,Claude Marcus,Daniele Sommacale,Maria-Angéla Castilla-Lièvre,Sophie Maitre,Lysiane Marthey +111 more
TL;DR: SarAH was a multicentre, open-label, randomised, controlled, investigator-initiated, phase 3 trial done at 25 centres specialising in liver diseases in France to compare the efficacy and safety of sorafenib to that of selective internal radiotherapy in patients with hepatocellular carcinoma.
Journal ArticleDOI
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
Yung-Jue Bang,E.P. Yanez Ruiz,E. Van Cutsem,Keun Wook Lee,Lucjan Wyrwicz,Michael Schenker,Maria Alsina,Min-Hee Ryu,Hyun Cheol Chung,Ludovic Evesque,S-E. Al-Batran,Silvia Park,M. Lichinitser,Narikazu Boku,Markus Moehler,Janet Hong,Huiling Xiong,R. Hallwachs,Ilaria Conti,Julien Taieb +19 more
TL;DR: Treatment of patients with GC/GEJC with single-agent avelumab in the third-line setting did not result in an improvement in OS or PFS compared with chemotherapy, and a Velumab showed a more manageable safety profile than chemotherapy.
Journal ArticleDOI
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
Eric Tartour,Hélène Péré,Bernard Maillere,Magali Terme,Nathalie Merillon,Julien Taieb,Federico Sandoval,Françoise Quintin-Colonna,Françoise Quintin-Colonna,K. Lacerda,A. Karadimou,Cécile Badoual,A. Tedgui,Wolf H. Fridman,Stéphane Oudard +14 more
TL;DR: In preclinical models, antiangiogenic molecules promoted intratumor trafficking of effector cells, enhance endogenous anti-tumor response, and synergyzed with immunotherapy protocols to cure established murine tumors warrant the development of clinical trials combining antiangIogenic drugs and immunotherapy.
Journal ArticleDOI
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer
Guy van Hazel,Volker Heinemann,Navesh K. Sharma,Michael Findlay,Jens Ricke,Marc Peeters,David Perez,Bridget A. Robinson,A. H. Strickland,Tom Ferguson,Javier Rodríguez,H. Kröning,Ido Wolf,Vinod Ganju,Euan Walpole,Eveline Boucher,Thomas Tichler,Einat Shacham-Shmueli,Alex Powell,Paul Eliadis,Richard Isaacs,David H. Price,Fred M. Moeslein,Julien Taieb,Geoff Bower,Val Gebski,Mark Van Buskirk,David N. Cade,Kenneth G. Thurston,Peter Gibbs +29 more
TL;DR: The addition of SIRT to FOLFOX-based first-line chemotherapy in patients with liver-dominant or liver-only metastatic colorectal cancer did not improve PFS at any site but significantly delayed disease progression in the liver.
Journal ArticleDOI
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Harpreet Wasan,Peter Gibbs,Navesh K Sharma,Julien Taieb,Volker Heinemann,Jens Ricke,Marc Peeters,Michael Findlay,Andrew Weaver,Jamie Mills,Charles Wilson,Richard Adams,Anne Francis,Joanna Moschandreas,P S Virdee,Peter Dutton,Sharon Love,Val Gebski,Alastair Gray,Andrew Bateman,Claire Blesing,Ewan Brown,Ian Chau,Sebastian Cummins,David Cunningham,Stephen Falk,Maher Hadaki,Marcia Hall,Tamas Hickish,Joanne Hornbuckle,F. Lofts,Sarah Lowndes,Astrid Mayer,Matthew Metcalfe,Gary Middleton,Amir Montazeri,Rebecca Muirhead,Andreas Polychronis,Colin Purcell,Paul Ross,Ricky A. Sharma,Liz Sherwin,David J. Smith,Rubin Soomal,Daniel Swinson,Axel Walther,Harpreet Wasan,Greg Wilson,Pradip Amin,Bruna Angelelli,Jacques Balosso,Alex Beny,Daniel Bloomgarden,Evelyn Boucher,Michael P. Brown,Harald-Robert Bruch,James Bui,Matthew Burge,Giuseppe Cardaci,James Carlisle,Seungjean Chai,Yi-Jen Chen,Patrick Chevallier,Michael Chuong,Stephen Clarke,Andrew L. Coveler,Michael Craninx,Thierry Delanoit,Amélie Deleporte,Paul Eliadis,Francis Facchini,Tom Ferguson,Michel Ferrante,Gary Frenette,Jacob Frick,Vinod Ganju,Michael Garofalo,Karen Geboes,Gerald Gehbauer,Benjamin George,Ravit Geva,Michael Gordon,Kate Gregory,Seza Gulec,James Hannigan,Guy van Hazel,Norman Isaac Heching,Thomas Helmberger,Alain Hendlisz,Koen Hendrickx,Matthew Holtzman,Richard Isaacs,Christopher Jackson,Philip T. James,Adeel Kaiser,Chris Karapetis,Andreas Kaubisch,Yon-Dschun Ko,H. Kröning,Frank Lammert,Winston Liauw,Steven Limentani,Samy Louafi,Marc De Man,Jeffrey Margolis,Robert C.G. Martin,Andrea Martoni,Gavin Marx,Marco Matos,E Monsaert,Veerle Moons,Louise M. Nott,Arnd Nusch,Anne O'Donnell,Howard Ozer,Siddarth A Padia,Nick Pavlakis,David Perez,Stefan Pluntke,Marc Polus,Alex Powell,Marc Pracht,Timothy J. Price,David Ransom,Christine Rebischung,Karsten Ridwelski,Jorge Riera-Knorrenschild,Hanno Riess,William S. Rilling,Bridget A. Robinson,Javier Rodríguez,Federico Sanchez,Tilmann Sauerbruch,Michael Savin,Klemens Scheidhauer,Elyse Schneiderman,Grant Seeger,Eva Segelov,Einat Shaham Schmueli,Adi Shani,Jenny Shannon,Navesh K. Sharma,Stephen Shibata,Nimit Singhal,Denis Smith,Randall Smith,Salomon M. Stemmer,Oliver Stötzer,Andrew Strickland,Klaus Tatsch,Eric Terrebonne,Thomas Tichler,Ursula Vehling-Kaiser,Ruth Vera-Garcia,Thomas J Vogl,Euan Walpole,Eric Wang,Samuel Whiting,Ido Wolf,Steven Ades,Morteza Aghmesheh,Miklos Auber,Hubert Ayala,Patrick McKay Boland,Eveline Bouche,Charles Bowers,Christoph Bremer,M. Burge,Ana Ruíz Casado,Prasad Cooray,Martin R. Crain,Maike De Wit,Kyran Dowling,Aurelie Durand,Sandrine Faivre,Kynan Feeney,Thomas W. Ferguson,Aurelie Ferru,Maria Fragoso,Cristina Granetto,Pascal Hammel,Richard Issacs,Renuka Iyer,Yeul Hong Kim,Jin-Tung Liang,Lionel Lim,Jin Hwang Liu,Gianluca Masi,Stefania Mosconi,Gianmauro Numico,Lynn Ratner,Han Sae-Won,Madhu Sudan Singh,Patricia Stoltzfus,Iain Tan,Antonio Trogu,Craig Underhill,Mark Westcott +197 more
TL;DR: Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent therapy for metastatic colorectal cancer has clinical benefit in patients with coloreCTal liver metastases with liver-dominant disease after chemotherapy.